Business
Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance
LOUISVILLE, Ky., November 05, 2025--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below.
About this update from Humana Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/1bec0f725adf3bf0a4edc0a438dc87ad"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/j05AuHNCJdLHSycrBVZcSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1bec0f725adf3bf0a4edc0a438dc87ad","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/q9KlrigTWchGKC3PmDMCfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/1bec0f725adf3bf0a4edc0a438dc87ad","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reports 3Q25 earnings per share (EPS) of $1.62 on a GAAP basis, Adjusted EPS of $3.24; reports YTD EPS of $16.43 on a GAAP basis, $21.10 on an Adjusted basis","length":157,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent'","length":152,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00'","length":201,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent","length":94,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Updates FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'approximately 425,000 members' compared to the previous guidance of a decline of 'up to 500,000 members'; driven by stronger retention and better-than-expected sales","length":279,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Furthers the advancement of the company's long-term strategy through growth in the CenterWell and Medicaid businesses","length":121,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Actively preparing for the January 1, 2026 launch of the initial phase-in of the Michigan Highl...